Insights from multi-omics integration in complex disease primary tissues
In 2018, a 39 amino-acid peptide tirzepatide (LY3298176) was developed, which is similar in size to both GLP-1 and GIP with exenatide-derived C-terminal tail and thus has a prolonged half-life
As hormone-mimicking therapies, GLP-1 and GLP-1/GIP act on natural pathways that help regulate appetite, insulin signaling, and inflammation
All options are available as a single pack, 2-pack bundle, or 4-pack bundle for ongoing supplementation
Impact of two neuronal Sigma-1 receptor modulators, PRE084 and DMT, on neurogenesis and neuroinflammation in an A142-injected, wild-type mouse model of AD